)
Mouwasat Medical Services Company (4002) investor relations material
Mouwasat Medical Services Company Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue increased to SR 3.22 billion in 2025, up from SR 2.88 billion in 2024, driven by growth in both medical services and pharmaceutical sales.
Net profit rose to SR 852 million in 2025, compared to SR 670 million in 2024, with EPS at SR 4.11 versus SR 3.23 year-over-year.
Gross profit improved to SR 1.36 billion, reflecting higher volumes and operational efficiency.
The group expanded its asset base to SR 5.99 billion, with significant investments in property, equipment, and new hospital projects.
Financial highlights
Medical services revenue reached SR 2.74 billion, and pharmaceutical sales SR 487 million in 2025.
Gross margin was 42.3% in 2025, up from 42.9% in 2024.
Operating profit increased to SR 880 million, up from SR 724 million year-over-year.
Cash flow from operations was SR 1.18 billion, with cash and equivalents at SR 497 million at year-end.
Total dividends declared for 2025 amounted to SR 425 million.
Outlook and guidance
Management expects continued growth from new hospital openings and expansion projects.
Capital commitments of SR 239 million are allocated for ongoing and future expansion.
No significant subsequent events were reported after year-end.
- Net profit rose 14.84% on 5.75% revenue growth, with strong cash flow and expansion.4002
Q1 202518 Feb 2026 - Strong revenue and profit growth supported by expansion and robust segment performance.4002
Q3 202526 Nov 2025 - Net profit and revenue increased year-over-year, supported by robust medical and pharmaceutical growth.4002
Q2 202518 Aug 2025 - Revenue and net profit increased, supported by robust medical and pharmaceutical operations.4002
Q2 202413 Jun 2025 - Revenue and net profit rose, with strong cash flow and strategic capital moves in 2024.4002
Q3 202413 Jun 2025 - Revenue up, net profit slightly down, strong cash flow and dividend proposed amid ongoing expansion.4002
Q4 20249 Jun 2025
Next Mouwasat Medical Services Company earnings date
Next Mouwasat Medical Services Company earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage